COMMUNIQUÉS West-GlobeNewswire

STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update

06/11/2024 - 14:15

HORSHAM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]

University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology

06/11/2024 - 14:25

ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at the University [...]

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates

06/11/2024 - 14:30

Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory IL-18 binding protein (IL- [...]

Safety Shot Expands Reach in Metro Chicago with New Distribution Agreement

06/11/2024 - 14:30

The Company's innovative alcohol-reducing beverage, Sure Shot, will be available in 450+ stores across the Chicago area. JUPITER, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” [...]

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024

06/11/2024 - 14:30

BASKING RIDGE, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and [...]

ICU Medical to Participate at the UBS Global Healthcare Conference

06/11/2024 - 14:30

SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present [...]

KFSHRC Implements Advanced Technology for Single-Step Cancerous Tissue Examination

06/11/2024 - 14:47

RIYADH, Saudi Arabia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Madinah has successfully implemented a novel technology, Large-Format Tissue Processing (Supa [...]

FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

06/11/2024 - 15:00

This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical [...]

Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event

06/11/2024 - 15:00

TORONTO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain [...]

Editas Medicine to Participate in Upcoming Investor Conferences

06/11/2024 - 15:00

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following upcoming investor [...]

AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast

06/11/2024 - 15:00

OCALA, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that management will host a conference call and webcast to discuss the Company’s Q3 2024 [...]

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

06/11/2024 - 15:00

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients with proof-of-concept data expected in the first half of 2025 Nominated novel portfolio of preclinical [...]

Alpha Pro Tech, Ltd. Announces Third Quarter 2024 Financial Results

06/11/2024 - 15:00

Overall sales decreased by 11.2% to $14.3 million compared to $16.1 million for the third quarter of 2023 Disposable Protective Apparel segment sales increased by 18.4% to $5.5 million compared to $4.6 million for the [...]

Jumeirah Hotels Leads Hospitality Innovation with Launch of Hapbee Wellness Technology in Dubai

06/11/2024 - 15:15

Luxury Hospitality Group to Offer Guests Customized Digital Sleep & Relaxation Featuring Hapbee Smart Sleep Pads and Immersive Mattress Toppers in Hotel Rooms and Spa VANCOUVER, British Columbia, Nov. 06, 2024 ( [...]

Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration

06/11/2024 - 15:23

Study will investigate the benefits of combining Lisata's novel product candidate, certepetide, with ValoTx's platform technology, PeptiCRAd, and a checkpoint inhibitor in preclinical tumor models BASKING RIDGE, N.J. [...]

The U.S. Patent Trial & Appeal Board Rules in Favor of Extremity Medical on Key Patent Claim, Despite Challenge by Fusion Orthopedics

06/11/2024 - 15:48

PARSIPPANY, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Extremity Medical, a global medical device company with expertise in innovative products for upper and lower extremities, is pleased to report that our U.S. Patent No [...]

Hydreight Technologies Inc. Ranks 9th in Deloitte’s Technology Fast 50 Program Winners for 2024

06/11/2024 - 11:45

VANCOUVER, British Columbia and LAS VEGAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing mobile clinical network [...]

Enterome to Present New Clinical Data and Biomarker Findings for EO2463 at the 2024 American Society of Hematology (ASH) Annual Meeting

06/11/2024 - 12:00

Two poster presentations to feature novel data from the Phase 1/2 SIDNEY trial of EO2463 in indolent Non-Hodgkin Lymphoma (iNHL), highlighting initial data from Cohort 2 as monotherapy in a “watch-and-wait” setting, and [...]

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024

06/11/2024 - 12:30

MANNHEIM, Germany, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it [...]